CSPG4 (Chondroitin Sulfate Proteoglycan 4) or Neuron-Glial Antigen 2 was originally thought to play a role in regulating the blood-brain barrier and tissue homeostasis but recently was found to function in various cell types and to be upregulated in many aggressive cancers as well (48). This evidence concerns the gene CSPG4 and cancer.